These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17964780)

  • 1. Synthesis and in vivo activity of MK2 and MK2 substrate-selective p38alpha(MAPK) inhibitors in Werner syndrome cells.
    Davis T; Bagley MC; Dix MC; Murziani PG; Rokicki MJ; Widdowson CS; Zayed JM; Bachler MA; Kipling D
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6832-5. PubMed ID: 17964780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Angle on MK2 Inhibition-Optimization and Evaluation of Prevention of Activation Inhibitors.
    Hedström U; Norberg M; Evertsson E; Lever SR; Munck Af Rosenschöld M; Lönn H; Bold P; Käck H; Berntsson P; Vinblad J; Liu J; Welinder A; Karlsson J; Snijder A; Pardali K; Andersson U; Davis AM; Mogemark M
    ChemMedChem; 2019 Oct; 14(19):1701-1709. PubMed ID: 31325352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of the p38α MAPK-MK2 axis inhibits inflammatory cues including inflammasome priming signals.
    Wang C; Hockerman S; Jacobsen EJ; Alippe Y; Selness SR; Hope HR; Hirsch JL; Mnich SJ; Saabye MJ; Hood WF; Bonar SL; Abu-Amer Y; Haimovich A; Hoffman HM; Monahan JB; Mbalaviele G
    J Exp Med; 2018 May; 215(5):1315-1325. PubMed ID: 29549113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAP Kinase-Mediated Activation of RSK1 and MK2 Substrate Kinases.
    Sok P; Gógl G; Kumar GS; Alexa A; Singh N; Kirsch K; Sebő A; Drahos L; Gáspári Z; Peti W; Reményi A
    Structure; 2020 Oct; 28(10):1101-1113.e5. PubMed ID: 32649858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a Novel Inhibitory Allosteric Site in p38α.
    Gomez-Gutierrez P; Campos PM; Vega M; Perez JJ
    PLoS One; 2016; 11(11):e0167379. PubMed ID: 27898710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross talk between the Akt and p38α pathways in macrophages downstream of Toll-like receptor signaling.
    McGuire VA; Gray A; Monk CE; Santos SG; Lee K; Aubareda A; Crowe J; Ronkina N; Schwermann J; Batty IH; Leslie NR; Dean JL; O'Keefe SJ; Boothby M; Gaestel M; Arthur JS
    Mol Cell Biol; 2013 Nov; 33(21):4152-65. PubMed ID: 23979601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-Anilino-6-phenyl-quinoline inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK2).
    Olsson H; Sjö P; Ersoy O; Kristoffersson A; Larsson J; Nordén B
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4738-40. PubMed ID: 20643547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoplasmic reticulum-associated ubiquitin-conjugating enzyme Ube2j1 is a novel substrate of MK2 (MAPKAP kinase-2) involved in MK2-mediated TNFα production.
    Menon MB; Tiedje C; Lafera J; Ronkina N; Konen T; Kotlyarov A; Gaestel M
    Biochem J; 2013 Dec; 456(2):163-72. PubMed ID: 24020373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine regulation by MAPK activated kinase 2 in keratinocytes exposed to sulfur mustard.
    Yego EC; Dillman JF
    Toxicol In Vitro; 2013 Oct; 27(7):2067-75. PubMed ID: 23851002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid synthesis of VX-745: p38 MAP kinase inhibition in Werner syndrome cells.
    Bagley MC; Davis T; Dix MC; Rokicki MJ; Kipling D
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5107-10. PubMed ID: 17659871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological and genetic inhibition of downstream targets of p38 MAPK in experimental nephrotic syndrome.
    Nie X; Chanley MA; Pengal R; Thomas DB; Agrawal S; Smoyer WE
    Am J Physiol Renal Physiol; 2018 Apr; 314(4):F602-F613. PubMed ID: 29187369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theoretical analysis of the binding of potential inhibitors to protein kinases MK2 and MK3.
    Araújo PM; da Silva LP; Esteves da Silva JC
    Med Chem; 2015; 11(6):573-9. PubMed ID: 25665652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-content screening analysis of the p38 pathway: profiling of structurally related p38alpha kinase inhibitors using cell-based assays.
    Ross S; Chen T; Yu V; Tudor Y; Zhang D; Liu L; Tamayo N; Dominguez C; Powers D
    Assay Drug Dev Technol; 2006 Aug; 4(4):397-409. PubMed ID: 16945013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells.
    Petrova T; Pesic J; Pardali K; Gaestel M; Arthur JSC
    Sci Rep; 2020 Feb; 10(1):3479. PubMed ID: 32103032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two additive mechanisms impair the differentiation of 'substrate-selective' p38 inhibitors from classical p38 inhibitors in vitro.
    Hendriks BS; Seidl KM; Chabot JR
    BMC Syst Biol; 2010 Mar; 4():23. PubMed ID: 20230629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-molecular-weight MK2 inhibitors: a tough nut to crack!
    Schlapbach A; Huppertz C
    Future Med Chem; 2009 Oct; 1(7):1243-57. PubMed ID: 21426101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding mode.
    Argiriadi MA; Ericsson AM; Harris CM; Banach DL; Borhani DW; Calderwood DJ; Demers MD; Dimauro J; Dixon RW; Hardman J; Kwak S; Li B; Mankovich JA; Marcotte D; Mullen KD; Ni B; Pietras M; Sadhukhan R; Sousa S; Tomlinson MJ; Wang L; Xiang T; Talanian RV
    Bioorg Med Chem Lett; 2010 Jan; 20(1):330-3. PubMed ID: 19919896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute lymphoid and gastrointestinal toxicity induced by selective p38alpha map kinase and map kinase-activated protein kinase-2 (MK2) inhibitors in the dog.
    Morris DL; O'Neil SP; Devraj RV; Portanova JP; Gilles RW; Gross CJ; Curtiss SW; Komocsar WJ; Garner DS; Happa FA; Kraus LJ; Nikula KJ; Monahan JB; Selness SR; Galluppi GR; Shevlin KM; Kramer JA; Walker JK; Messing DM; Anderson DR; Mourey RJ; Whiteley LO; Daniels JS; Yang JZ; Rowlands PC; Alden CL; Davis JW; Sagartz JE
    Toxicol Pathol; 2010 Jun; 38(4):606-18. PubMed ID: 20448081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of MK2 shows promise for preventing postoperative ileus in mice.
    Liu X; Wu T; Chi P
    J Surg Res; 2013 Nov; 185(1):102-12. PubMed ID: 23764316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural analysis of an MK2-inhibitor complex: insight into the regulation of the secondary structure of the Gly-rich loop by TEI-I01800.
    Fujino A; Fukushima K; Namiki N; Kosugi T; Takimoto-Kamimura M
    Acta Crystallogr D Biol Crystallogr; 2010 Jan; 66(Pt 1):80-7. PubMed ID: 20057052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.